Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation

Schmidt, HH; Wixner, J; Plante-Bordeneuve, V; Munoz-Beamud, F; Llado, L; Gillmore, JD; Mazzeo, A; Li, XY; Arum, S; Jay, PY; Adams, D

Schmidt, HH (通讯作者),Univ Duisburg Essen, Univ Hosp Essen, Dept Gastroenterol Hepatol & Transplant Med, Essen, Germany.

AMERICAN JOURNAL OF TRANSPLANTATION, 2022; 22 (6): 1646

Abstract

Hereditary transthyretin-mediated (hATTR) amyloidosis, or ATTRv amyloidosis, is a progressive disease, for which liver transplantation (LT) has been a......

Full Text Link